A little over a year into the COVID-19 pandemic, Indian companies have 20 publicly known COVID-19 vaccines in development, on platforms ranging from modern nucleic acid to the traditional inactivated/weakened virus.
Three have made the cut so far, with the domestic regulator approving Serum Institute of India Pvt. Ltd